631 related articles for article (PubMed ID: 24160812)
1. Rate of re-excision after breast-conserving surgery for invasive lobular carcinoma.
Wanis ML; Wong JA; Rodriguez S; Wong JM; Jabo B; Ashok A; Lum SS; Solomon NL; Reeves ME; Garberoglio CA; Senthil M
Am Surg; 2013 Oct; 79(10):1119-22. PubMed ID: 24160812
[TBL] [Abstract][Full Text] [Related]
2. Role for intraoperative margin assessment in patients undergoing breast-conserving surgery.
Cabioglu N; Hunt KK; Sahin AA; Kuerer HM; Babiera GV; Singletary SE; Whitman GJ; Ross MI; Ames FC; Feig BW; Buchholz TA; Meric-Bernstam F
Ann Surg Oncol; 2007 Apr; 14(4):1458-71. PubMed ID: 17260108
[TBL] [Abstract][Full Text] [Related]
3. The safety of multiple re-excisions after lumpectomy for breast cancer.
Coopey S; Smith BL; Hanson S; Buckley J; Hughes KS; Gadd M; Specht MC
Ann Surg Oncol; 2011 Dec; 18(13):3797-801. PubMed ID: 21630123
[TBL] [Abstract][Full Text] [Related]
4. Optimal use of re-excision in patients diagnosed with early-stage breast cancer by excisional biopsy treated with breast-conserving therapy.
Caughran JL; Vicini FA; Kestin LL; Dekhne NS; Benitez PR; Goldstein NS
Ann Surg Oncol; 2009 Nov; 16(11):3020-7. PubMed ID: 19636632
[TBL] [Abstract][Full Text] [Related]
5. Clinical-pathologic features, long term-outcome and surgical treatment in a large series of patients with invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC).
Biglia N; Maggiorotto F; Liberale V; Bounous VE; Sgro LG; Pecchio S; D'Alonzo M; Ponzone R
Eur J Surg Oncol; 2013 May; 39(5):455-60. PubMed ID: 23490334
[TBL] [Abstract][Full Text] [Related]
6. Surgical management of lobular carcinoma from a national screening program: a retrospective analysis.
Sharma SD; Barry M; O'Reilly EA; Kell MR
Eur J Surg Oncol; 2015 Jan; 41(1):79-85. PubMed ID: 25441933
[TBL] [Abstract][Full Text] [Related]
7. Role of re-excision for positive and close resection margins in patients treated with breast-conserving surgery.
Biglia N; Ponzone R; Bounous VE; Mariani LL; Maggiorotto F; Benevelli C; Liberale V; Ottino MC; Sismondi P
Breast; 2014 Dec; 23(6):870-5. PubMed ID: 25305040
[TBL] [Abstract][Full Text] [Related]
8. Re-excision rates of invasive ductal carcinoma with lobular features compared with invasive ductal carcinomas and invasive lobular carcinomas of the breast.
Arps DP; Jorns JM; Zhao L; Bensenhaver J; Kleer CG; Pang JC
Ann Surg Oncol; 2014 Dec; 21(13):4152-8. PubMed ID: 24980090
[TBL] [Abstract][Full Text] [Related]
9. Impact of Using Intra-Operative Ultrasound Guided Breast- Conserving Surgery on Positive Margin and Re-Excision Rates in Breast Cancer Cases with Current SSO/ASTRO Guidelines.
Thanasitthichai S; Chaiwerawattana A; Phadhana-Anake O
Asian Pac J Cancer Prev; 2016; 17(9):4463-4467. PubMed ID: 27797262
[TBL] [Abstract][Full Text] [Related]
10. Review of re-excision for narrow or positive margins of invasive and intraductal carcinoma.
Gupta A; Subhas G; Dubay L; Silapaswan S; Kolachalam R; Kestenberg W; Ferguson L; Jacobs MJ; Gorieil Y; Mittal VK
Am Surg; 2010 Jul; 76(7):731-4. PubMed ID: 20698380
[TBL] [Abstract][Full Text] [Related]
11. Factors associated with re-excision in patients with early-stage breast cancer treated with breast conservation therapy.
Sanchez C; Brem RF; McSwain AP; Rapelyea JA; Torrente J; Teal CB
Am Surg; 2010 Mar; 76(3):331-4. PubMed ID: 20349668
[TBL] [Abstract][Full Text] [Related]
12. Re-resection rates and risk characteristics following breast conserving surgery for breast cancer and carcinoma in situ: A single-centre study of 1575 consecutive cases.
Kryh CG; Pietersen CA; Rahr HB; Christensen RD; Wamberg P; Lautrup MD
Breast; 2014 Dec; 23(6):784-9. PubMed ID: 25227964
[TBL] [Abstract][Full Text] [Related]
13. A two-millimetre free margin from invasive tumour minimises residual disease in breast-conserving surgery.
Ward ST; Jones BG; Jewkes AJ
Int J Clin Pract; 2010 Nov; 64(12):1675-80. PubMed ID: 20946273
[TBL] [Abstract][Full Text] [Related]
14. The Yale University experience of early-stage invasive lobular carcinoma (ILC) and invasive ductal carcinoma (IDC) treated with breast conservation treatment (BCT): analysis of clinical-pathologic features, long-term outcomes, and molecular expression of COX-2, Bcl-2, and p53 as a function of histology.
Moran MS; Yang Q; Haffty BG
Breast J; 2009; 15(6):571-8. PubMed ID: 19995377
[TBL] [Abstract][Full Text] [Related]
15. Patients with invasive lobular breast cancer are less likely to undergo breast-conserving surgery: a population based study in the Netherlands.
Truin W; Roumen RM; Siesling S; van der Heiden-van der Loo M; Duijm LE; Tjan-Heijnen VC; Voogd AC
Ann Surg Oncol; 2015 May; 22(5):1471-8. PubMed ID: 25323475
[TBL] [Abstract][Full Text] [Related]
16. Reoperation Rates in Ductal Carcinoma In Situ vs Invasive Breast Cancer After Wire-Guided Breast-Conserving Surgery.
Langhans L; Jensen MB; Talman MM; Vejborg I; Kroman N; Tvedskov TF
JAMA Surg; 2017 Apr; 152(4):378-384. PubMed ID: 28002557
[TBL] [Abstract][Full Text] [Related]
17. The effects of additional tumor cavity sampling at the time of breast-conserving surgery on final margin status, volume of resection, and pathologist workload.
Rizzo M; Iyengar R; Gabram SG; Park J; Birdsong G; Chandler KL; Mosunjac MB
Ann Surg Oncol; 2010 Jan; 17(1):228-34. PubMed ID: 19636625
[TBL] [Abstract][Full Text] [Related]
18. Sampling of secondary margins decreases the need for re-excision after partial mastectomy.
Guidroz JA; Larrieux G; Liao J; Sugg SL; Scott-Conner CE; Weigel RJ
Surgery; 2011 Oct; 150(4):802-9. PubMed ID: 22000194
[TBL] [Abstract][Full Text] [Related]
19. Intraoperative touch preparation cytology for margin assessment in breast-conservation surgery: does it work for lobular carcinoma?
Valdes EK; Boolbol SK; Ali I; Feldman SM; Cohen JM
Ann Surg Oncol; 2007 Oct; 14(10):2940-5. PubMed ID: 17632761
[TBL] [Abstract][Full Text] [Related]
20. A Single institution's randomized double-armed prospective study of lumpectomy margins with adjunctive use of the MarginProbe in nonpalpable breast cancers.
Geha RC; Taback B; Cadena L; Borden B; Feldman S
Breast J; 2020 Nov; 26(11):2157-2162. PubMed ID: 32772474
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
